# Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases

> **NCT03433196** · PHASE3 · COMPLETED · sponsor: **Zhejiang Hisun Pharmaceutical Co. Ltd.** · enrollment: 255 (actual)

## Conditions studied

- Hypercholesterolemia in Coronaory Heart Disease

## Interventions

- **DRUG:** HS-25 and Atorvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT03433196
- **Lead sponsor:** Zhejiang Hisun Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-07
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-10-10
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433196, "Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03433196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*